Angiodynamic Inc
ANGO
Market Cap$397.14M
Close$
$-5.68
157.3% downside
Current Fair Value
157.3% downsideOvervalued by 157.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $397.14 Million |
|---|---|
| Enterprise Value | $358.34 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.59 |
| Beta | 0.62 |
| Outstanding Shares | 40,853,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.65 |
|---|---|
| PEG | 9.88 |
| Price to Sales | 1.65 |
| Price to Book Ratio | 2.48 |
| Enterprise Value to Revenue | 1.26 |
| Enterprise Value to EBIT | -11.7 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Angiodynamic Inc
CEO: James Clemmer AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines in...